Targeted metabolomics analysis displayed elevated S-adenosyl-methionine (SAM) and metabolite S-adenosyl-homocysteine (SAH), a cofactor and metabolite of PRMT5, respectively, in ibrutinib-resistant MCL cell lines (Supplementary Fig. S2e). This evidence concerns the gene PRMT5 and mantle cell lymphoma.